Oligator R oligonucleotides iv

Related by string. * : Oligator R oligonucleotides / Rs . Rd . red . R. : MS RD . Rs #.# [005] . Bill Frist R Tenn . R Ind / Oligonucleotides . Oligonucleotide : situ synthesized oligonucleotide arrays . antisense oligonucleotide . antisense oligonucleotides . oligonucleotide ligation / IVS . IVs . IVD . Iver : Street Fighter IV . Sid Meier Civilization IV . Paragraph IV certification * *

Related by context. Frequent words. (Click for all words.) 62 y h 62 h g 61 h y 60 y r 60 y u 59 h o 59 h u 59 h r 59 u h 58 n h 58 o h 57 P. #a 57 r h 57 d h 57 t r 57 i g 57 f o 56 w l 56 className nodes nodes.length = 55 f h 55 u t 55 o l 53 r t 53 NanoSemiconductor Company 53 l y 53 l o 53 g h 53 f r 53 l h 53 g o 52 Vernon Supp 52 FINANCIAL CONDITION AND 51 DSL.net s 51 CNA ir 51 BioSante licensees 51 p r 50 TranSwitch filings 50 TranSwitch indebtedness 50 o t 50 FREE Whitepaper 50 r n 50 State Farm Mut 50 r l 49 l l 49 risks associated therewith 49 Ariba logo AribaLIVE 49 golf sportswear sweaters 49 Copegus R 47 Activision Publishing maintains 47 Rosetta dependence 47 h l 47 EPIX Pharmaceuticals 46 Prelude SkinPrep Systems 46 Income Tax Regs 46 Vertical Networks 46 immunohistochemical 46 peripheral blood mononuclear 46 Slip op 46 Nortel strategic alliances 46 T#I [002] 46 CNA ct 46 subds 45 h w 45 Sanger sequencing 45 cmt 45 Somaxon ability 45 render Cree 45 abilityto 45 molecular profiling 45 antisense oligonucleotides 45 suchforward looking 45 party VLSI fabrication 45 regarding Heska 45 Mago ® 44 MGCD# MGCD# [002] 44 IoGen 44 microarray analysis 44 AlloMap 44 w r 44 theforward looking 44 OSI Pharmaceuticals filings 44 site www.buyins.net 44 CFR § #.# [006] 43 gene expression profiling 43 cytogenetic 43 Web site http:/www.EmergingStockReport.com 43 novel ZFP TFs 43 Dyax utilizes 43 theability 43 successfully commercialize REOLYSIN 43 Announces Stockholder Approval 43 While Ambrilia anticipates 43 AzaSite Plus 43 unfavorable geologic 43 surety bonding increased 43 celgosivir 42 Market Disruption 42 Evid 42 consummating acquisitions 42 PD2i Analyzer ™ 42 successfully commercialize

Back to home page